Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
BPC-157 Benefits and Research Applications BPC-157 has evidenced many exciting therapeutic effects in clinical studies
Phase 3 clinical trials testing GLP-1 RAs for weight management have demonstrated mean weight reduction of 8% to 15%, with 63% to 86% of patients achieving a 5% or greater reduction in body weight, and 33% to 69% achieving a 10% or greater reduction after 13 to 17 months of use
PMID 12527699
Researchers must comply with all applicable institutional, state, and federal regulations governing the use of research chemicals
The cognitive benefit data is preliminary but compelling, and the longevity medicine community is watching that research space closely
10, 30 Apr
US$ 21.82
US$ 21.62
US$ 28.16
US$ 23.43
US$ 29.32
US$ 22.23
US$ 26.38
US$ 23.23
